Smart Radiation Therapy Biomaterials

International Journal of Radiation Oncology Biology Physics

Volumn 97, Issue 3, 2017, Pages 624-637

  Ngwa, Wilfred ^a,b   Boateng, Francis ^a   Kumar, Rajiv ^c   Irvine, Darrell J ^d   Formenti, Silvia ^e   Ngoma, Twalib ^f   Herskind, Carsten ^g   Veldwijk, Marlon R ^g   Hildenbrand, Georg Lars ^g   Hausmann, Michael ^h   Wenz, Frederik ^g   Hesser, Juergen ^g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d Massachusetts Institute of Technology   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DISEASES; ONCOLOGY; PATIENT TREATMENT; TUMORS;

CLINICAL APPLICATION; CONTROLLED DELIVERY; CROSS-DISCIPLINARY RESEARCH; FUNCTIONALIZED NANOPARTICLES; GEOMETRIC ACCURACY; NORMAL-TISSUE TOXICITY; RESEARCH AND DEVELOPMENT; SMART BIOMATERIALS;

RADIOTHERAPY;

BIOMATERIAL; NANOPARTICLE;

BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; FIDUCIAL MARKER; HEALTH CARE COST; HUMAN; IMAGE GUIDED RADIOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; ARTIFICIAL INTELLIGENCE; PROCEDURES;

ARTIFICIAL INTELLIGENCE; BIOCOMPATIBLE MATERIALS; BRACHYTHERAPY; FIDUCIAL MARKERS; HUMANS; NANOPARTICLES; RADIOTHERAPY, IMAGE-GUIDED;

EID: 85009944195     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.10.034     Document Type: Review

References (100)

1. 1 Atun, R., Jaffray, D.A., Barton, M.B., et al. Expanding global access to radiotherapy. Lancet Oncol 16 (2015), 1153–1186.
2. 2 Canter, D., Greenberg, R.E., Horwitz, E.M., et al. Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT. Can J Urol 17 (2010), 5365–5369.
3. 3 Balter, J.M., Wright, J.N., Newell, L.J., et al. Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005), 933–937.
4. 4 Ng, M., Brown, E., Williams, A., et al. Fiducial markers and spacers in prostate radiotherapy: Current applications. BJU Int 113 (2014), 13–20.
5. 5 Dempsey, J.F., Williams, J.A., Stubbs, J.B., et al. Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins. Int J Radiat Oncol Biol Phys 42 (1998), 421–429.
6. 6 Cifter, G., Chin, J., Cifter, F., et al. Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles. Phys Med 31 (2015), 1070–1074.
7. 7 Ngwa, W., Kumar, R., Sridhar, S., et al. Targeted radiotherapy with gold nanoparticles: Current status and future perspectives. Nanomedicine (Lond) 9 (2014), 1063–1082.
8. 8 Kumar, R., Belz, J., Markovic, S., et al. Nanoparticle-based brachytherapy spacers for delivery of localized combined chemoradiation therapy. Int J Radiat Oncol Biol Phys 91 (2015), 393–400.
9. 9 Nagesha, D.K., Tada, D.B., Stambaugh, C.K., et al. Radiosensitizer-eluting nanocoatings on gold fiducials for biological in-situ image-guided radio therapy (BIS-IGRT). Phys Med Biol 55 (2010), 6039–6052.
10. 10 Sinha, N., Cifter, G., Sajo, E., et al. Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters. Int J Radiat Oncol Biol Phys 91 (2015), 385–392.
11. 11 Cormack, R.A., Sridhar, S., Suh, W.W., et al. Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices. Int J Radiat Oncol Biol Phys 76 (2010), 615–623.
12. 12 Langer, R., Tirrell, D.A., Designing materials for biology and medicine. Nature 428 (2004), 487–492.
13. 13 Anderson, D.G., Burdick, J.A., Langer, R., Materials science: Smart biomaterials. Science 305 (2004), 1923–1924.
14. 14 Mieszawska, A.J., Kaplan, D.L., Smart biomaterials: Regulating cell behavior through signaling molecules. BMC Biol, 8, 2010, 59.
15. 15 Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12 (2013), 991–1003.
16. 16 Stuart, M.A., Huck, W.T., Genzer, J., et al. Emerging applications of stimuli-responsive polymer materials. Nat Mater 9 (2010), 101–113.
17. 17 Hainfeld, J.F., Slatkin, D.N., Smilowitz, H.M., The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49 (2004), N309–N315.
18. 18 Ouyang, Z., Mainali, M.K., Sinha, N., et al. Potential of using cerium oxide nanoparticles for protecting healthy tissue during accelerated partial breast irradiation (APBI). Phys Med 32 (2016), 631–635.
19. 19 Ngwa, W., Ngoma, T., Emerging models for global health in radiation oncology. 2016, IOP Publishing, Bristol, Philadelphia.
20. 20 Lasagna-Reeves, C., Gonzalez-Romero, D., Barria, M.A., et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393 (2010), 649–655.
21. 21 Fransen, M.F., Cordfunke, R.A., Sluijter, M., et al. Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer. Vaccine 32 (2014), 1654–1660.
22. 22 Sandin, L.C., Orlova, A., Gustafsson, E., et al. Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer. Cancer Immunol Res 2 (2014), 80–90.
23. 23 Kumar, R., Korideck, H., Ngwa, W., et al. Third generation gold nanoplatform optimized for radiation therapy. Transl Cancer Res, 2, 2013.
24. 24 Burger, N., Biswas, A., Barzan, D., et al. A method for the efficient cellular uptake and retention of small modified gold nanoparticles for the radiosensitization of cells. Nanomedicine 10 (2014), 1365–1373.
25. 25 Sullivan, L.B., Chandel, N.S., Mitochondrial reactive oxygen species and cancer. Cancer Metab, 2, 2014, 17.
26. 26 Tada, D.B., Singh, S., Nagesha, D., et al. Chitosan film containing poly(d,l-lactic-co-glycolic acid) nanoparticles: A platform for localized dual-drug release. Pharm Res 27 (2010), 1738–1745.
27. 27 Markovic, S., Belz, J., Kumar, R., et al. Near-infrared fluorescence imaging platform for quantifying in vivo nanoparticle diffusion from drug loaded implants. Int J Nanomedicine 11 (2016), 1213–1223.
28. 28 Altundal, Y., Cifter, G., Detappe, A., et al. New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect. Phys Med 31 (2015), 25–30.
29. 29 Hao, Y., Altundal, Y., Moreau, M., et al. Potential for enhancing external beam radiotherapy for lung cancer using high-z nanoparticles administered via inhalation. Phys Med Biol 60 (2015), 7035–7043.
30. 30 Cifter, G., Altundal, Y., Detappe, A., et al. Dose enhancement during concomitant chemoradiotherapy using FDA approved concentrations of carboplatin and oxaliplatin nanoparticles. Jaffray, A.D., (eds.) World Congress on Medical Physics and Biomedical Engineering, June 7-12, 2015, Toronto, Canada, 2015, Springer International Publishing, Cham, 1723–1726.
31. 31 Schuemann, J., Berbeco, R., Chithrani, D.B., et al. Roadmap to clinical use of gold nanoparticles for radiation sensitization. Int J Radiat Oncol Biol Phys 94 (2016), 189–205.
32. 32 Rancoule, C., Magne, N., Vallard, A., et al. Nanoparticles in radiation oncology: From bench-side to bedside. Cancer Lett 375 (2016), 256–262.
33. 33 Baetke, S.C., Lammers, T., Kiessling, F., Applications of nanoparticles for diagnosis and therapy of cancer. Br J Radiol, 88, 2015, 20150207.
34. 34 Jain, S., Hirst, D.G., O'Sullivan, J.M., Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 85 (2012), 101–113.
35. 35 Prise, K.M., Martin, S.G., Editorial—nanoparticles for diagnostic imaging and radiotherapy. Br J Radiol, 88, 2015, 20150692.
36. 36 Lux, F., Sancey, L., Bianchi, A., et al. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Nanomedicine (Lond) 10 (2015), 1801–1815.
37. 37 Pottier, A., Borghi, E., Levy, L., The future of nanosized radiation enhancers. Br J Radiol, 88, 2015, 20150171.
38. 38 Friedman, A.D., Claypool, S.E., Liu, R., The smart targeting of nanoparticles. Curr Pharm Des 19 (2013), 6315–6329.
39. 39 Nicol, J.R., Dixon, D., Coulter, J.A., Gold nanoparticle surface functionalization: A necessary requirement in the development of novel nanotherapeutics. Nanomedicine (Lond) 10 (2015), 1315–1326.
40. 40 Boisselier, E., Astruc, D., Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38 (2009), 1759–1782.
41. 41 Mieszawska, A.J., Mulder, W.J., Fayad, Z.A., et al. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm 10 (2013), 831–847.
42. 42 Curry, T., Kopelman, R., Shilo, M., et al. Multifunctional theranostic gold nanoparticles for targeted ct imaging and photothermal therapy. Contrast Media Mol Imaging 9 (2014), 53–61.
43. 43 de Barros, A.B., Tsourkas, A., Saboury, B., et al. Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res, 2, 2012, 39.
44. 44 Kim, B., Han, G., Toley, B.J., et al. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 5 (2010), 465–472.
45. 45 Allemann, E., Brasseur, N., Benrezzak, O., et al. Peg-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to emt-6 mouse mammary tumours. J Pharm Pharmacol 47 (1995), 382–387.
46. 46 Fredman, G., Kamaly, N., Spolitu, S., et al. Targeted nanoparticles containing the proresolving peptide ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med, 7, 2015, 275ra220.
47. 47 Dhar, S., Gu, F.X., Langer, R., et al. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A 105 (2008), 17356–17361.
48. 48 Dhar, S., Kolishetti, N., Lippard, S.J., et al. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A 108 (2011), 1850–1855.
49. 49 Farokhzad, O.C., Cheng, J., Teply, B.A., et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 103 (2006), 6315–6320.
50. 50 Fan, Y., Moon, J.J., Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy. Vaccines (Basel) 3 (2015), 662–685.
51. 51 Hainfeld, J.F., O'Connor, M.J., Lin, P., et al. Infrared-transparent gold nanoparticles converted by tumors to infrared absorbers cure tumors in mice by photothermal therapy. PLoS One, 9, 2014, e88414.
52. 52 Singhana, B., Slattery, P., Chen, A., et al. Light-activatable gold nanoshells for drug delivery applications. AAPS PharmSciTech 15 (2014), 741–752.
53. 53 Dane, E.L., Irvine, D.J., Big thinking for adjuvants. Nat Biotechnol 33 (2015), 1146–1148.
54. 54 Irvine, D.J., Swartz, M.A., Szeto, G.L., Engineering synthetic vaccines using cues from natural immunity. Nat Mater 12 (2013), 978–990.
55. 55 Saluja, S.S., Hanlon, D.J., Sharp, F.A., et al. Targeting human dendritic cells via dec-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen. Int J Nanomedicine 9 (2014), 5231–5246.
56. 56 Demaria, S., Ng, B., Devitt, M.L., et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 58 (2004), 862–870.
57. 57 Mitra, A., Nan, A., Line, B.R., et al. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr Pharm Des 12 (2006), 4729–4749.
58. 58 Song, J., Kim, J., Hwang, S., et al. “Smart” gold nanoparticles for photoacoustic imaging: An imaging contrast agent responsive to the cancer microenvironment and signal amplification via ph-induced aggregation. Chem Commun (Camb) 52 (2016), 8287–8290.
59. 59 Zhang, D.G., Feygelman, V., Moros, E.G., et al. Monte Carlo study of radiation dose enhancement by gadolinium in megavoltage and high dose rate radiotherapy. PLoS One, 9, 2014, e109389.
60. 60 Yang, Y.S., Carney, R.P., Stellacci, F., et al. Enhancing radiotherapy by lipid nanocapsule-mediated delivery of amphiphilic gold nanoparticles to intracellular membranes. ACS Nano 8 (2014), 8992–9002.
61. 61 DeMuth, P.C., Min, Y., Irvine, D.J., et al. Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization. Adv Healthc Mater 3 (2014), 47–58.
62. 62 DeMuth, P.C., Li, A.V., Abbink, P., et al. Vaccine delivery with microneedle skin patches in nonhuman primates. Nat Biotechnol 31 (2013), 1082–1085.
63. 63 Franzen, S., Lommel, S.A., Targeting cancer with ‘smart bombs’: Equipping plant virus nanoparticles for a ‘seek and destroy’ mission. Nanomedicine (Lond) 4 (2009), 575–588.
64. 64 Yavuz, M.S., Cheng, Y., Chen, J., et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 8 (2009), 935–939.
65. 65 Wong, C., Stylianopoulos, T., Cui, J., et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A 108 (2011), 2426–2431.
66. 66 Kim, T.J., Chae, K.S., Chang, Y., et al. Gadolinium oxide nanoparticles as potential multimodal imaging and therapeutic agents. Curr Top Med Chem 13 (2013), 422–433.
67. 67 Yang, X.L., Ju, X.J., Mu, X.T., et al. Core-shell chitosan microcapsules for programmed sequential drug release. ACS Appl Mater Interfaces 8 (2016), 10524–10534.
68. 68 DeMuth, P.C., Min, Y., Huang, B., et al. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater 12 (2013), 367–376.
69. 69 Egunov, A.I., Inaba, A., Gree, S., et al. Time-programmed release of fluoroscein isocyanate dextran from micro-pattern-designed polymer scrolls. J Control Release 233 (2016), 39–47.
70. 70 Priya James, H., John, R., Alex, A., et al. Smart polymers for the controlled delivery of drugs: A concise overview. Acta Pharm Sin B 4 (2014), 120–127.
71. 71 Adhikary, R.R., More, P., Banerjee, R., Smart nanoparticles as targeting platforms for HIV infections. Nanoscale 7 (2015), 7520–7534.
72. 72 Lutz, E.R., Wu, A.A., Bigelow, E., et al. Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunol Res 2 (2014), 616–631.
73. 73 Lendlein, A., Jiang, H., Junger, O., et al. Light-induced shape-memory polymers. Nature 434 (2005), 879–882.
74. 74 Celli, J.P., Rizvi, I., Blanden, A.R., et al. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci Rep, 4, 2014, 3751.
75. 75 Glaser, A.K., Zhang, R., Andreozzi, J.M., et al. Cherenkov radiation fluence estimates in tissue for molecular imaging and therapy applications. Phys Med Biol 60 (2015), 6701–6718.
76. 76 Glaser, A.K., Zhang, R., Gladstone, D.J., et al. Optical dosimetry of radiotherapy beams using Cherenkov radiation: The relationship between light emission and dose. Phys Med Biol 59 (2014), 3789–3811.
77. 77 Kotagiri, N., Sudlow, G.P., Akers, W.J., et al. Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat Nanotechnol 10 (2015), 370–379.
78. 78 Ouyang, Z., Liu, B., Yasmin-Karim, S., et al. Nanoparticle-aided external beam radiotherapy leveraging the Čerenkov effect. Phys Med 32 (2016), 944–947.
79. 79 Lucky, S.S., Muhammad Idris, N., Li, Z., et al. Titania coated upconversion nanoparticles for near-infrared light triggered photodynamic therapy. ACS Nano 9 (2015), 191–205.
80. 80 Brahim, S., Narinesingh, D., Guiseppi-Elie, A., Bio-smart hydrogels: Co-joined molecular recognition and signal transduction in biosensor fabrication and drug delivery. Biosens Bioelectron 17 (2002), 973–981.
81. 81 Purdy, J.A., Dose to normal tissues outside the radiation therapy patient's treated volume: A review of different radiation therapy techniques. Health Phys 95 (2008), 666–676.
82. 82 Keall, P.J., Mageras, G.S., Balter, J.M., et al. The management of respiratory motion in radiation oncology report of AAPM task group 76. Med Phys 33 (2006), 3874–3900.
83. 83 Machtay, M., Bae, K., Movsas, B., et al. Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 82 (2012), 425–434.
84. 84 Berbeco, R.I., Korideck, H., Ngwa, W., et al. DNA damage enhancement from gold nanoparticles for clinical mV photon beams. Radiat Res 178 (2012), 604–608.
85. 85 Ngwa, W., Korideck, H., Kassis, A.I., et al. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine 9 (2013), 25–27.
86. 86 Dreaden, E.C., Austin, L.A., Mackey, M.A., et al. Size matters: Gold nanoparticles in targeted cancer drug delivery. Ther Deliv 3 (2012), 457–478.
87. 87 Seo, S.E., Kang, Y.O., Jung, S.H., et al. Synthesis of radioisotope mn-56@sio2, sm-153@sio2, and dy-165@sio2 hybrid nanoparticles for use as radiotracer. J Nanosci Nanotechnol 15 (2015), 7221–7228.
88. 88 Mole, R.H., Whole body irradiation: Radiobiology or medicine?. Br J Radiol 26 (1953), 234–241.
89. 89 Tang, C., Wang, X., Soh, H., et al. Combining radiation and immunotherapy: A new systemic therapy for solid tumors?. Cancer Immunol Res 2 (2014), 831–838.
90. 90 Golden, E.B., Demaria, S., Schiff, P.B., et al. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 1 (2013), 365–372.
91. 91 Datta, N.R., Samiei, M., Bodis, S., Are state-sponsored new radiation therapy facilities economically viable in low- and middle-income countries?. Int J Radiat Oncol Biol Phys 93 (2015), 229–240.
92. 92 Moser, F., Hildenbrand, G., Muller, P., et al. Cellular uptake of gold nanoparticles and their behavior as labels for localization microscopy. Biophys J 110 (2016), 947–953.
93. 93 Hao Y, Yasmin-Karim S, Moreau M, Sinha N, Sajo E, Ngwa W, Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in-situ from new design radiotherapy biomaterials: a preclinical study. Phys in Med Biol. in press.
94. 94 Weigelt, B., Peterse, J.L., Van't Veer, L.J., Breast cancer metastasis: Markers and models. Nat Rev Cancer 5 (2005), 591–602.
95. 95 Errico, A., Radiotherapy: A double-edged sword for NSCLC?. Nat Rev Clin Oncol, 11, 2014, 66.
96. 96 Wang, X., Qian, X., Beitler, J.J., et al. Detection of circulating tumor cells in human peripheral blood using surface-enhanced raman scattering nanoparticles. Cancer Res 71 (2011), 1526–1532.
97. 97 Miller, M.C., Doyle, G.V., Terstappen, L.W., Significance of circulating tumor cells detected by the cellsearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol, 2010, 2010, 617421.
98. 98 Baumann, M., Krause, M., Overgaard, J., et al. Radiation oncology in the era of precision medicine. Nat Rev Cancer 16 (2016), 234–249.
99. 99 Arcangeli, S., Greco, C., Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more?. Nat Rev Urol 13 (2016), 400–408.
100. 100 Mortimer, J.W., McLachlan, C.S., Hansen, C.J., et al. Use of hypofractionated post-mastectomy radiotherapy reduces health costs by over $2000 per patient: An Australian perspective. J Med Imaging Radiat Oncol 60 (2016), 146–153.